PMID- 9034148 OWN - NLM STAT- MEDLINE DCOM- 19970314 LR - 20240213 IS - 0022-1007 (Print) IS - 1540-9538 (Electronic) IS - 0022-1007 (Linking) VI - 185 IP - 4 DP - 1997 Feb 17 TI - The immunodominant antigen of an ultraviolet-induced regressor tumor is generated by a somatic point mutation in the DEAD box helicase p68. PG - 695-705 AB - The genetic origins of CD8+ T cell-recognized unique antigens to which mice respond when immunized with syngeneic tumor cells are unknown. The ultraviolet light-induced murine tumor 8101 expresses an H-2Kb-restricted immunodominant antigen, A, that induces cytolytic CD8+ T cells in vivo A+ 8101 cells are rejected by naive mice while A- 8101 tumor cells grow. To identify the antigen H-2Kb molecules were immunoprecipitated from A+ 8101 cells and peptides were eluted by acid. The sensitizing peptide was isolated by sequential reverse-phase HPLC and sequenced using microcapillary HPLC-triple quadruple mass spectrometry. The peptide, SNFVFAGI, matched the sequence of the DEAD box protein p68 RNA helicase except for a single amino acid substitution, caused by a single nucleotide change. This mutation was somatic since fibroblasts from the mouse of tumor origin expressed the wild-type sequence. The amino acid substitution created an anchor for binding of the mutant peptide to H-2Kb. Our results are consistent with mutant p68 being responsible for rejection of the tumor. Several functions of p68, which include nucleolar assembly and inhibition of DNA unwinding, may be mediated through its IQ domain, which was altered by the mutation. This is the first description of a somatic tumor-specific mutation in the coding region of a nucleic acid helicase. FAU - Dubey, P AU - Dubey P AD - Department of Pathology, The University of Chicago, Illinois 60637, USA. FAU - Hendrickson, R C AU - Hendrickson RC FAU - Meredith, S C AU - Meredith SC FAU - Siegel, C T AU - Siegel CT FAU - Shabanowitz, J AU - Shabanowitz J FAU - Skipper, J C AU - Skipper JC FAU - Engelhard, V H AU - Engelhard VH FAU - Hunt, D F AU - Hunt DF FAU - Schreiber, H AU - Schreiber H LA - eng GR - R01CA37156/CA/NCI NIH HHS/United States GR - R01 CA037156/CA/NCI NIH HHS/United States GR - P01 CA019266/CA/NCI NIH HHS/United States GR - R01 AI033993/AI/NIAID NIH HHS/United States GR - R01 AI020963/AI/NIAID NIH HHS/United States GR - R01CA22677/CA/NCI NIH HHS/United States GR - R01CA19266/CA/NCI NIH HHS/United States GR - R01 CA022677/CA/NCI NIH HHS/United States PT - Journal Article PT - Research Support, U.S. Gov't, P.H.S. PL - United States TA - J Exp Med JT - The Journal of experimental medicine JID - 2985109R RN - 0 (Antigens) RN - 0 (DNA, Complementary) RN - 0 (H-2 Antigens) RN - 0 (H-2Kb protein, mouse) RN - 0 (Immunodominant Epitopes) RN - EC 2.7.- (Protein Kinases) RN - EC 2.7.7.- (RNA Nucleotidyltransferases) RN - EC 3.6.1.- (Ddx5 protein, mouse) RN - EC 3.6.4.13 (DEAD-box RNA Helicases) RN - EC 3.6.4.13 (RNA Helicases) SB - IM MH - Amino Acid Sequence MH - Animals MH - Antigens/*immunology MH - Base Sequence MH - CD8-Positive T-Lymphocytes/immunology MH - DEAD-box RNA Helicases MH - DNA, Complementary MH - Female MH - H-2 Antigens/immunology MH - Immunodominant Epitopes/*immunology MH - Mice MH - Mice, Inbred C57BL MH - Molecular Sequence Data MH - Neoplasms, Experimental/immunology MH - *Point Mutation MH - *Protein Kinases MH - *RNA Helicases MH - RNA Nucleotidyltransferases/*genetics PMC - PMC2196148 EDAT- 1997/02/17 00:00 MHDA- 1997/02/17 00:01 PMCR- 1997/08/17 CRDT- 1997/02/17 00:00 PHST- 1997/02/17 00:00 [pubmed] PHST- 1997/02/17 00:01 [medline] PHST- 1997/02/17 00:00 [entrez] PHST- 1997/08/17 00:00 [pmc-release] AID - 10.1084/jem.185.4.695 [doi] PST - ppublish SO - J Exp Med. 1997 Feb 17;185(4):695-705. doi: 10.1084/jem.185.4.695.